Woodruff: Clinical Research Should Be More Gender-Specific



Loading...

By Deborah Borfitz

June 16, 2008 | In virtually every medical discipline, there are unanswered questions pertaining to women’s health and well-being. Closing the gender gap in medical research may require more than simply including women in research studies, says Teresa Woodruff, executive director of the Institute for Women’s Health Research, recently launched by Northwestern University’s Feinberg School of Medicine.

“Women experience disease symptoms and respond to therapeutic treatments differently throughout their lifespan and across their monthly menstrual cycle,” says Woodruff. Hormone fluctuations and the possibility of pregnancy among pre-menopausal women have for decades been the rationale for excluding females from medical research. To this day, many researchers prefer using male animals over female animals in their laboratories simply because their hormone environment is less complicated.

 Teresa Woodruff,  Institute for Women's Health, Northwestern University 
Teresa Woodruff
Since the early 1990s, women have been represented as study subjects in higher numbers because the National Institutes of Health, as a condition of funding, now requires that researchers include women in all studies targeting diseases that impact both sexes. However, when male and female trial data gets blended, sex- and gender-specific findings are difficult to evaluate unless the trial was specifically designed to look for sexual dimorphisms, says Woodruff.

Traditionally, women’s health research has focused on issues such as pregnancy, menopause, and female-specific cancers, she adds. Only in the last five years, for example, has the medical community identified sex differences in cardiovascular disease, the leading killer of both men and women. Even far less is known about diagnosing and treating women with diseases of the brain, the musculoskeletal organs, and the immune system. Most reports on adverse drug reactions occur in women because females were not included in many of the early pharmaceutical studies.

Woodruff believes that women want to be a part of the answer. The Institute’s latest project, the Illinois Women’s Health Registry, opened three months ago and has already enrolled over 1,000 Illinois women who are willing to take part in Institutional Review Board-approved research conducted at Northwestern University. Registry participants will be matched to specific studies based on their self-reported health profiles. Woodruff says she hopes the registry “will help us identify priorities that will raise the health status of Illinois women, who now rank 33rd among the states.”

In addition to the registry, the Institute for Women’s Health Research is facilitating more women’s research by offering seed grants to young investigators and by developing an Animal Research Core that will encourage researchers to use female animal models in their studies.

“More physicians are beginning to recognize that sex and gender impact health, but they do not necessarily know the way it relates to age or genetics,” says Woodruff. “That level of sophistication doesn’t exist yet.” But “before we can get to personalized medicine, we need to understand basic sex differences.”

Woodruff predicts, “Ten years from now, the treatment of women and men will be different than it is today because of programs like the Institute for Women’s Health Research.”

________________________________

 This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

oracle_clinical
eClinical Visions - Clinical Trial Management: Enabling Operational Efficiency
Sponsored by Oracle

Read how contributors from Genzyme, Duke Clinical Research Institute, Accenture, Oracle Health Sciences and others address some of the most pertinent challenges facing the biopharmaceutical industry including... Globalization of clinical trials driven by the need to reduce costs and recruit participants; greater outsourcing; escalating regulatory demands; increased trial complexity; and post-marketing studies. Download this paper to gain new insight into:

  • Recent progress made in addressing these challenges
  • Expert opinion on clinical trial management systems (CTMS) for improving trial efficiencies
  • How to cut trial costs and enhance the productivity of trial participants


oracle_RDC
Remote Data Capture – Acquisition and Analysis
Sponsored by Oracle

Today nearly half of all clinical trials are conducted electronically, and rising! Electronic Data Capture (EDC) technology provides industry-wide opportunities, along with challenges, that are being addressed. In this informative report industry experts and users from Pfizer, PPD, C3i and Oracle Health Sciences discuss the impact of EDC and its newest zero footprint; online iteration.  It can used anywhere, world-wide, where the Internet is available while placing greater onus on global trial support. The critical focus of this new technology is that it must support the work of the person at the heart of the clinical trial system– the investigator. Download this report to learn more about:

  • Trends and Issues in an Electronic Clinical Data Management World
  • The New Remote Data Capture Paradigm 
  • Improving and Monitoring Clinical Data Management in the eClinical Age
  • Optimizing and Supporting Remote Data Capture


oracle_video
Technology Video Report: A Day in the Life with Remote Data Capture (Next-Gen EDC)
Sponsored by Oracle
See why Oracle Remote Data Capture (RDC) Onsite is the next generation in electronic data capture with its user-friendly method to collect, clean, review, and verify clinical trial data. Providing unprecedented performance with real-time data capture, Oracle RDC Onsite simplifies source data verification. With a clear, consistent view of study data across all sites, the benefits include reduced monitoring time, decreased queries and discrepancies, and less time to database lock.



Life Science Webcasts & Podcasts

Predict or Perish! Shaping the Practices of Clinical Trials
Decisionview webinarSponsored by:  DecisionView

Predictive Analytics are a key differentiator in running your clinical trials successfully through 2010 and beyond. They will help you to optimize your patient enrollment, reduce your clinical operations costs and minimize your financial liability in the clinical supply chain. In this session, you will:
• Learn what predictive analytics are and what they are not
• Understand why you need predictive analytics to run your clinical trials, and
• Explore how predictive analytics will shape the future of clinical trials

Download Now. 

 



More Podcasts

Job Openings

The University of Washington Department of Genome Sciences is seeking a LINUX SYSTEMS ENGINEERING MANAGER to lead a team in a diverse scientific computing environment that includes multiple HPC systems, petascale storage, and custom application servers. Apply online at UW Hires for req number 61505.  http://www.washington.edu/admin/hr/jobs/

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.